<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are myeloid disorders with various clinical and biological presentations </plain></SENT>
<SENT sid="1" pm="."><plain>The French-American-British (FAB-1982) classification included five categories basing on <z:mp ids='MP_0000002'>morphology</z:mp> and bone marrow blast count </plain></SENT>
<SENT sid="2" pm="."><plain>Three criteria are taken into account: 1) the percentage of blasts in peripheral blood and bone marrow, 2) the percentage of ringed sideroblasts, and 3) the number of monocytes in peripheral blood </plain></SENT>
<SENT sid="3" pm="."><plain>The World Health Organization classification (WHO 2001, 2008) modifies the FAB system by also taking cytogenetic characteristics and molecular biology into consideration </plain></SENT>
<SENT sid="4" pm="."><plain>The last classification (WHO-2008) takes into account: 1) the number of peripheral cytopenia, 2) the percentage of blasts in peripheral blood and bone marrow, 3) the percentage of ringed sideroblasts, 4) the possible presence of Auer Rods, and 5) the detection of a cytogenetic abnormality (the isolated 5q deletion) </plain></SENT>
<SENT sid="5" pm="."><plain>The following subgroups are defined: refractory cytopenia with unilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo>, refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> unclassifiable and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with isolated del(5q) </plain></SENT>
</text></document>